1. Chief executive officer of Aviron, a research-stage company applying genetic engineering to create new vaccines for infectious diseases, and has served as a founder, senior executive, director, or active investor in a number of biotechnology companies.
2. Life Sciences Industry Services, at Ernst and Young, one of the leading international accounting and professional services firms.